RBM10 and cancer: RBM10 is significantly overexpressed in many malignant tumors, and it inhibits the proliferation and clonal formation ability of A549 cells and enhances the sensitivity of A549 cells to the chemotherapy drug paclitaxel by inducing apoptosis.